This table shows the list known insiders, and is generated automatically from filings disclosed to the SEC. In addition to the names, most recent title, and director, officer, or 10% owner designation, we provide the latest disclosed holdings.
| Name | Shares | Options |
|---|---|---|
| Sumitomo Chemical Co., Ltd. | 50,041,181 | 0 |
| Takeda Pharmaceuticals International AG By Millennium Pharmaceuticals , Inc. | 7,420,625 | 0 |
| KARBE FRANK | 163,470 | 0 |
| Arjona Ferreira Juan Camilo | 145,115 | 0 |
| Sablich Kim | 58,905 | 0 |
| Lang Matthew | 34,597 | 0 |
| VIKING GLOBAL PERFORMANCE LLC Explanation of Responses | 0 | 0 |
| Ramaswamy Vivek | 0 | 0 |
| Marek David C | 0 | 0 |
| DeVeydt Wayne S | 0 | 0 |
| Merendino Lauren | 0 | 0 |
| Gulfo Adele M. | 0 | 0 |
| VIKING GLOBAL INVESTORS LP | 0 | 0 |
| QVT Associates GP LLC | 0 | 0 |
| Shabet Rose Sharon See Explanation of Responses | 0 | 0 |
| Oren Dan See footnote. | 0 | 0 |
| Mehra Uneek | 0 | 0 |
| Sebelius Kathleen | 0 | 0 |
| Dexxon Holdings Ltd. | 0 | 0 |
| Torti Frank | 0 | 0 |
| Machado Patrick See footnote. | 0 | 0 |
| Romeo Marianne L. | 0 | 0 |
| QVT Fund V LP See Explanation of Responses | 0 | 0 |
| GUINAN MARK | 0 | 0 |
| Sundheim Daniel S. See Explanation of Responses | 0 | 0 |
| Sumitovant Biopharma Ltd. | 0 | 0 |
| MILLENNIUM PHARMACEUTICALS INC | 0 | 0 |
| Roivant Sciences Ltd. | 0 | 0 |
| 0 | 0 | |
| VIKING GLOBAL INVESTORS LP See Explanation of Responses | 0 | 0 |
| VIKING GLOBAL PERFORMANCE LLC | 0 | 0 |
| SVF Investments (UK) Ltd See Explanation | 0 | 0 |
| Lo Andrew | 0 | 0 |
| POTTER MYRTLE S | 0 | 0 |
| Valente Nancy | 0 | 0 |
| Seely Lynn | 0 | 0 |
| Lo Andrew See footnote. | 0 | 0 |
| Curran Terrie | 0 | 0 |
| Viking Global Equities Master Ltd. See Explanation of Responses | 0 | 0 |
| QVT Associates GP LLC see fn | 0 | 0 |
| Altmeyer Mark | 0 | 0 |
| Dexcel Pharma Technologies Ltd. | 0 | 0 |
| Takeda Pharmaceuticals International AG | 0 | 0 |
| Viking Long Fund Master Ltd. See Explanation of Responses | 0 | 0 |
| MANCHESTER KEITH S | 0 | 0 |
| Machado Patrick | 0 | 0 |
| Nishinaka Shigeyuki | 0 | 0 |
| Nomura Hiroshi | 0 | 0 |
While Insider sales are normal part of tax harvesting and is part of compensation of executives - A large number of transactions would indicate that the management isnt convinced that the price will go up and hence reducing their holding. This would be a possible indicator or fall in price
| Name | Shares | Price | Date |
|---|
Insider buys arent usual, since it indicates a high conviction by the management that they believe the price will go up eventually. Usually a good sign that investors should consider this as a factor to purchase a stock, especially if the current SP is lower than the price the management bought these at. The table below doesnt include any Stock Options or RSUs. They're just open market purchases by the insiders.
| Name | Shares | Price | Date |
|---|